CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.225
-0.085 (-3.68%)
Jul 9, 2025, 4:00 PM - Market closed

CytoMed Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
263956---
Upgrade
Market Cap Growth
-30.55%-30.55%----
Upgrade
Enterprise Value
233549---
Upgrade
Last Close Price
2.253.404.90---
Upgrade
PS Ratio
70.40106.38146.86---
Upgrade
PB Ratio
3.955.926.63---
Upgrade
P/TBV Ratio
3.996.046.64---
Upgrade
EV/Sales Ratio
61.4493.59127.72---
Upgrade
Debt / Equity Ratio
0.050.050.047.201.266.27
Upgrade
Asset Turnover
0.050.050.060.060.020.02
Upgrade
Inventory Turnover
0.040.040.010.020.010.03
Upgrade
Quick Ratio
8.398.3912.830.390.860.35
Upgrade
Current Ratio
9.899.8914.080.601.120.54
Upgrade
Return on Equity (ROE)
-24.86%-24.86%-69.87%-197.08%-133.79%-161.72%
Upgrade
Return on Assets (ROA)
-17.44%-17.44%-27.30%-20.55%-21.98%-24.47%
Upgrade
Return on Capital (ROIC)
-18.46%-18.46%-29.12%-21.82%-23.38%-27.26%
Upgrade
Earnings Yield
-7.10%-4.70%-5.54%---
Upgrade
FCF Yield
-12.36%-7.68%-4.81%---
Upgrade
Buyback Yield / Dilution
-8.56%-8.56%-34.30%-14.14%-17.59%-6.22%
Upgrade
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q